Moneycontrol PRO

business

Dr Reddy's Q1 net profit seen up 25% YoY to Rs 421 cr

The generic drugs maker's earnings will be boosted by strong growth in the US and Russian generics drugs market and better currency realisations.

first published: Jul 29, 2013 06:17 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347